Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P837: Cause and risk factors of death in patients with intestinal Behcet's DiseaseECCO '18 Vienna
Year: 2018
Authors:

E.J. Yoo, S.J. Park*, Y. Park, J.H. Cheon, T.I. Kim, W.H. Kim

Yonsei University College of Medicine, Internal medicine, Seoul, South Korea

P838: Complicated disease in East Asian patients with ulcerative colitis over two decades: A single-centre retrospective cohort in JapanECCO '18 Vienna
Year: 2018
Authors:

T. Taida1*, J. Kumagai1, S. Ogasawara1, Y. Ohta1, S. Hamanaka1, M. Nakamura1, H. Ohyama1, K. Saito1, Y. Kusakabe1, S. Yasui1, H. Sugiyama1, Y. Sakai1, R. Mikata1, T. Nakagawa1, T. Katsuno2, T. Tsuyuguchi1, N. Kato1

1Chiba University, Department of Gastroenterology, Chiba, Japan, 2Chiba University, Kashiwanoha Clinic of East Asian Medicine, Kashiwa, Japan

P839: Clinical and sociodemographical characteristics of inflammatory bowel disease in Mexico: Multicentric nation-wide study (EPIMEX-IBD)ECCO '18 Vienna
Year: 2018
Authors:

J. Yamamoto-Furusho1*, A. Sarmiento1, J. Toledo-Mauriño1, K. Bozada-Gutiérrez1, F. Bosques-Padilla2, M. Martínez-Vázquez3, V. Marroquín-Jiménez4, R. García-Figueroa5, C. Jaramillo-Buendía6, R. Miranda-Cordero7, J. Valenzuela-Pérez8, Y. Cortes-Aguilar9, J. Jacobo-Karam10, E. Bermudez-Villegas11, E. Study Group12

1IBD Clinic, Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico, Mexico, 2Hospital San Jose Tec de Monterrey, Monterrey, Mexico, 3Hospital Universitario Dr. Jose e Gonzalez, Department of Gastroenterology, Monterrey, Mexico, 4Hospital de Especialidades Centro Medico Nacional General Manuel Avila Camacho IMSS, Gastroenterology, Puebla, Mexico, 5Hospital de Alta Especialidad ISSSTE, Gastroenterology, Morelia, Mexico, 6Hospital General Regional 110 IMSS, Gastroenterology, Guadalajara, Mexico, 7Centro Médico ISSEMyM, Gastroenterology, Toluca, Mexico, 8Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Colorectal Surgery, Guadalajara, Mexico, 9Hospital “Gomez Farias” ISSSTE, Endoscopy, Guadalajara, Mexico, 10Hospital General 450 Secretaría de Salud, Gastroenterology, Durango, Mexico, 11Hospital Regional 25 IMSS, Gastroenterology, Mexico, Mexico, 12EPIMEX Study Group, Gastroenterology, Whole country, Mexico

P840: IBD-related malignancies and mortalities observed in 2015–2017: 3 years’ results from the prospective nationwide Hungarian registryECCO '18 Vienna
Year: 2018
Authors:

T. Molnar1*, F. Nagy1, P. Fritz2, L. Lakatos3, Z. Erdélyi3, P. Miheller4, T. Szamosi5, E. Schafer5, A. Vincze6, P. Sarlós6, J. Banai5, A. Kovács7, J. Novák8, A. Salamon9, A. Szepes10, N. Szigeti11, M. Juhász4, K. Müllner4, Z. Barta12, O. Kadenczki12, A. Gelley13, K. Palatka14, M. Papp12, A. Zaránd15, P. Lakatos16, G. Veres17, M. Rutka1, A. Balint1, R. Bor1, A. Milassin1, A. Fábián1, Z. Szepes1, K. Farkas1

1University of Szeged, 1st Department of Medicine, Szeged, Hungary, 2St. Francis Hospital, Kalocsa, Hungary, 3Csolnoky Ferenc Veszprém County Hospital, Veszprém, Hungary, 4Semmelweis University, 2nd Department of Medicine, Budapest, Hungary, 5State Health Centre, Department of Gastroenterology, Budapest, Hungary, 6University of Pécs, 1st Department of Internal Medicine, Pécs, Hungary, 7Péterfy Sándor Hospital and Trauma Center, Budapest, Hungary, 8Bekes County Pandy Kalman Hospital, Gyula, Hungary, 9Tolna County Balassa Janos Hospital, Gastroenterology Department, Szekszárd, Hungary, 10Bács-Kiskun County University Teaching Hospital, Kecskemét, Hungary, 11University of Pécs, 2nd Department of Internal Medicine and Nephrology Centre, Pécs, Hungary, 12University of Debrecen, Debrecen, Hungary, 13Budai Irgalmasrendi Hospital, Budapest, Hungary, 14University of Debrecen, 2nd Department of Internal Medicine, Debrecen, Hungary, 15Semmelweis University, 1st Department of Surgery, Budapest, Hungary, 16Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 17Semmelweis University, Department of Pediatrics, Budapest, Hungary

P841: A novel candidate pathway for development of in patients atypical serrated lesions with KRAS mutation in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

M. Nishio1,2*, W. Shibata2,3, R. Kunisaki1, Y. Ajioka4, K. Hirasawa5, W. Ueda6, K. Okawa6, Y. Hashimoto1, H. Otake1, T. Ogashiwa1, A. Takase7, S. Chiba7, Y. Inayama7, H. Kimura1, S. Maeda2

1Yokohama City University Medical Centre, Inflammatory Bowel Disease Centre, Yokohama, Japan, 2Yokohama City University Graduate School of Medicine, Department of Gastroenterology, Yokohama, Japan, 3Yokohama City University, Advanced Medical Research Centre, Yokohama, Japan, 4Niigata University Graduate School of Medical and Dental Sciences, Division of Molecular and Diagnostic Pathology, Niigata, Japan, 5Yokohama City University Medical Centre, Division of Endoscopy, Yokohama, Japan, 6Osaka City Juso Hospital, Department of Gastroenterology and Hepatology, Osaka, Japan, 7Yokohama City University Medical Centre, Department of Diagnostic Pathology, Yokohama, Japan

P842: Aberrant lipid metabolism in patients with DGAT1 deficiencyECCO '18 Vienna
Year: 2018
Authors:

J.M. van Rijn1,2, R.C. Ardy3,4*, A. Kansu5, B. Härter6, D.Y. van Haaften–Visser1,2, M. Ng3,4, Z. Kuloğlu5, M.K. Başaran7, F. Ozcay8, H. van der Doef9, P.J. Coffer2, T. Müller10, R.H. Houwen1, G. van Haaften11, A.R. Janecke10, S. Middendorp1,2, K. Boztug3,4,12,13

1Wilhelmina Children’s Hospital, University Medical Center Utrecht (UMCU), Department of Pediatric Gastroenterology, Utrecht, The Netherlands, 2University Medical Center Utrecht (UMCU), Regenerative Medicine Center, Utrecht, The Netherlands, 3Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Boztug Laboratory, Vienna, Austria, 4CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria, 5Ankara University, Department of Pediatric Gastroenterology, Ankara, Turkey, 6Medical University of Innsbruck, Department of Visceral, Transplant and Thoracic Surgery, Innsbruck, Austria, 7Akdeniz University Medicine Hospital, Pediatric Gastroenterology Department, Antalya, Turkey, 8Başkent University, Department of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Ankara, Turkey, 9University Medical Center Groningen, Department of Pediatric Gastroenterology, Hepatology and Nutrition, Gronigen, The Netherlands, 10Medical University of Innsbruck, Department of Pediatrics I, Innsbruck, Austria, 11University Medical Center Utrecht (UMCU), Department of Medical Genetics, Utrecht, The Netherlands, 12Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria, 13Medical University of Vienna, St. Anna Kinderspital and Children’s Cancer Research Institute, Department of Pediatrics, Vienna, Austria

P843: Upadacitinib-induced endoscopic improvement is associated with modulation of pathways involved in Crohn’s disease pathogenesisECCO '18 Vienna
Year: 2018
Authors:

D. Aguilar1*, N. Planell1, J. Panés1, A. Lacerda2, J. Butler2, J.W. Davis2, A. Salas1

1IDIBAPS-Hospital Clínic Barcelona, CIBER-EHD, Barcelona, Spain, 2AbbVie Inc., North Chicago, USA

P844: NGS to investigate genetic predisposition to colon cancer in patients with colon cancer over inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

G. Biscaglia1, A. Latiano1, S. Castellana2, F. Bossa1, D. Scimeca1, A. Gentile1, T. Latiano1, G. Corritore1, M. Nardella1, G. Martino1, T. Mazza2, A. Andriulli1, O. Palmieri1*

1IRCCS, Casa Sollievo della Sofferenza, Hospital, UOC Gastroenterology, San Giovanni Rotondo, Italy, 2IRCCS Casa Sollievo della Sofferenza, Unit of Bioinformatics, San Giovanni Rotondo, Italy

P845: Compound heterozygous mutations in IL10RA combined with a hemizygous CFP mutation acting as a potential modifier in infantile-onset inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

E.S. Jung1,2*, B.-S. Petersen1, J.H. Cheon2, Y. Kang3, W.H. Kim2, S. Kim3, S. Schreiber1, A. Franke1, H. Koh3

1Institut für Klinische Molekularbiologie, Kiel, Germany, 2Yonsei University College of Medicine, Internal Medicine and Institute of Gastroenterology, Seoul, South Korea, 3Yonsei University College of Medicine, Pediatrics, Seoul, South Korea

P846: Genetics, methylation, and disease state interact at the VMP1/MIR21 locusECCO '18 Vienna
Year: 2018
Authors:

K. O'Leary*, A. Adams, E. Nimmo, N. Ventham, J. Satsangi

University of Edinburgh, IGMM, EDINBURGH, UK

P847: IBDomics: systems biology-based analysis of inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

J. Pazmandi1,2*, J. Menche2, K. Boztug1,2,3,4

1Ludwig Boltzmann Institute Rare and Undiagnosed Diseases, Vienna, Austria, 2CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria, 3Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria, 4St. Anna Kinderspital and Childrens‘ Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Vienna, Austria

P848: FXR -1G>T (rs56163822) predicts deleterious outcomes in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

A. Wilson1*, W. Teft2, A. Al-Mousa2, R. Kim3

1Western University, Department of Gastroenterology, London, Canada, 2Western University, London, Canada, 3Western University, Department of Medicine, London, Canada

P849: Genetic variation within the NKG2D pathway may influence the response to anti-NKG2D therapy in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

A. Hart1, E. Neiman1, J. Perrigoue1, L.-Y. Hao1, L. Tomsho1, W. Schultz1, A. Di Narzo2, K. Hao2, B. Skolnick3, T. Ort1, M. Curran1, S. Plevy1, M. Allez4*

1Janssen Research and Development, LLC, Spring House, USA, 2Icahn School of Medicine at Mount Sinai, New York, USA, 3Novo Nordisk, Inc., Princeton, USA, 4Hôpital Saint-Louis, Dpt. Gastroenterology and Hepatology, Paris, France

P850: Genetic variants of MGAT5 gene are associated with ulcerative colitis severity and response to therapyECCO '18 Vienna
Year: 2018
Authors:

M.S. Pereira1,2*, C. Durães1, T.A. Catarino1, I. Cleynen3, R. Marcos-Pinto2,4, J.C. Machado1,5, F. Magro6, S. Vermeire3, P. Lago4, S.S. Pinho1,5

1Institute for Research and Innovation in Health (i3S), Porto, Portugal, 2Institute of Biomedical Sciences of Abel Salazar (ICBAS), University of Porto, Porto, Portugal, 3Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium, 4Centro Hospitalar do Porto, Department of Gastroenterology, Porto, Portugal, 5Faculty of Medicine, University of Porto, Porto, Portugal, 6Department of Gastroenterology, Centro Hospitalar de São João, Porto, Portugal

P851: Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitisECCO '18 Vienna
Year: 2018
Authors:

L. Koeninger1*, N.S. Armbruster1, Z. Hu2, B. Jensen3, E.F. Stange1, P. Nordkild4, N.P. Malek1, L. Zender2, J. Wehkamp1

1University Hospital Tuebingen, Internal Medicine I, Tuebingen, Germany, 2Universtiy Hosptial Tuebingen, Internal Medicine VIII, Tuebingen, Germany, 3Universtiy of Laval, Department for Medicine, Quebec, Canada, 4Defensin Therapeutics, Copenhagen, Denmark

P852: A metabolomics approach to discover biomarkers of chronic intestinal inflammation associated with gut microbiota dysbiosis in ulcerative colitis and Celiac DiseaseECCO '18 Vienna
Year: 2018
Authors:

S. Sitkin1,2*, T. Vakhitov1, E. Tkachenko3, E. Avalueva2, L. Oreshko2, T. Zhigalova2, E. Demyanova1, O. Shalaeva1, V. Utsal4, M. Suvorova5, E. Komlichenko6

1State Research Institute of Highly Pure Biopreparations of FMBA, Department of Microbiology, St. Petersburg, Russian Federation, 2North-Western State Medical University named after I.I. Mechnikov, Department of Internal Diseases, Gastroenterology and Dietetics, St. Petersburg, Russian Federation, 3Kirov Military Medical Academy, St. Petersburg, Russian Federation, 4Institute of Toxicology of FMBA, St. Petersburg, Russian Federation, 5Institute of Experimental Medicine, St. Petersburg, Russian Federation, 6Almazov Federal Medical Research Centre, St. Petersburg, Russian Federation

P853: Immunoglobulin G selectively binds pathobionts in the terminal ileum of paediatric IBD patientsECCO '18 Vienna
Year: 2018
Authors:

H. Armstrong, M. Alipour, R. Valcheva, P. Shah, D. Zaidi, J. Jovel, G. Wong, M. Carroll, H. Huynh, L. Dieleman, E. Wine*

University of Alberta, Edmonton, Canada

P854: Quantitative microbiome profiling changes the described dysbiotic state in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

C. Caenepeel1,2*, S. Vieira-Silva3, J. Sabino1,2, K. Machiels1, G. Falony3, M. Ferrante1,2, G. Van Assche1,2, J. Raes3, S. Vermeire1,2

1KU Leuven, The Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), Leuven, Belgium, 2UZ Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 3KU Leuven, Rega Institute, Department of Microbiology and Immunology, Leuven, Belgium

P855: Vegetarian and gluten-free diet in patients with IBD—associated with a different microbiota compared with omnivore IBD patientsECCO '18 Vienna
Year: 2018
Authors:

P. Schreiner1*, B. Yilmaz2, Y. Franc3, J.-B. Rossel3, B. Misselwitz1, M. Scharl1, J. Zeitz4, P. Frei5, T. Greuter1, S. Vavricka6, V. Pittet3, A. Siebenhüner7, P. Juillerat8, R. von Känel9, A. Macpherson2, G. Rogler1, L. Biedermann1

1UniversityHospital of Zurich, Gastroenterology and Hepatology, Zurich, Switzerland, 2University of Bern, Department of Clinical Research Gastroenterology and Mucosal Immunology, Bern, Switzerland, 3Lausanne University Hospital, Institute of Social and Preventive Medicine, Lausanne, Switzerland, 4Klinik Hirslanden, Center of Gastroenterology, Zurich, Switzerland, 5Gastroenterology Bethanien, Zurich, Switzerland, 6Center of Gastroenterology and Hepatology, Zurich, Switzerland, 7UniversityHospital of Zurich, Hematology and Oncology, Zurich, Switzerland, 8Inselspital Bern University Hospital, Department of Visceral Surgery and Medicine, Bern, Switzerland, 9Clinic Barmelweid, Department of Psychosomatic Medicine, Barmelweid, Switzerland

P856: The gut microbiota composition and metabolic activity of HLA-B27 transgenic rats with gut inflammation resembles the dysbiotic characteristics of human inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

V. Svolos1*, B. Nichols1, D. Bolognini2, C. Quince3, U.Z. Ijaz4, R.T. Papadopoulou1, C. Ansalone5, J. Salmond6, R. Klopfleisch7, D.R. Gaya8, R.K. Russell9, R. Hansen9, K. Gerasimidis1, S. Milling5

1Human Nutrition, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK, 2Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK, 3Warwick Medical School, University of Warwick, Warwick, UK, 4School of Engineering, University of Glasgow, Glasgow, UK, 5Institute of Infection, Immunity and Inflammation, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK, 6Queen Elizabeth University Hospital, Glasgow, UK, 7Institute of Veterinary Pathology, Freie Universitaet, Berlin, Germany, 8Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK, 9Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK